封面
市場調查報告書
商品編碼
1816644

2025年全球監理事務外包市場報告

Regulatory Affairs Outsourcing Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年監管外包市場將快速成長,到2029年將達到159.7億美元,年複合成長率(CAGR)為14.1%。預測期內,推動這一成長的因素包括監管提交日益複雜、監管流程數位轉型、對合規性和風險管理的日益重視、產品開發趨勢的變化以及監管提交日益複雜。預測期內的主要趨勢包括生命科學產業的擴張、永續性和環境法規、對策略指導的需求、高階分析的使用以及強化的風險管理。

未來五年14.1%的成長預測比我們先前的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。在美國,由於製藥和醫療器材公司從瑞士和印度採購監管情報平台、跨境文件工具和自動化審核系統的成本越來越高,合規管理成本預計將會增加。此外,互惠關稅以及不斷升級的醫療設備摩擦和限制對全球經濟和貿易的負面影響可能會產生更廣泛的影響。

預計專注於新疫苗、治療藥物和醫療設備的研發 (R&D) 活動的預期成長將成為監管外包市場的主要驅動力。從事醫療設備、製藥和生物技術領域的公司正在增加對研發的投資,以創造創新產品並擴大其全球影響力。同時,這些公司擴大選擇外包其監管事務職能,以最佳化營運成本並利用該領域專業人士的專業知識來加快監管流程。例如,由醫療保險和醫療補助服務中心 (CMS) 精算師辦公室編寫的 2022 年 3 月國家衛生支出 (NHE) 報告預測,從 2021 年到 2030 年,國家醫療保健支出將以年均 5.1% 的速度成長,到 2030 年將達到約 6.8 兆美元。因此,新疫苗、治療藥物和醫療設備研發活動的激增預計將推動監管外包市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章 市場 - 宏觀經濟情境宏觀經濟情境包括利率、通貨膨脹、地緣政治、貿易戰和關稅,以及 COVID-19 大流行和復甦對市場的影響。

第5章 全球成長分析與策略分析框架

  • 全球製藥外包:PESTEL分析(政治、社會、科技、環境、法律因素、促進因素與限制因素)
  • 最終用途產業分析
  • 全球監理事務外包市場:成長率分析
  • 全球監理外包市場表現:規模與成長,2019-2024
  • 全球監理外包市場預測:規模與成長,2024-2029 年,2034 年
  • 全球監理外包:總目標市場(TAM)

第6章 市場細分

  • 全球醫藥事務外包市場:依服務、績效與預測,2019-2024 年、2024-2029 年、2034 年
  • 法律代表
  • 監理諮詢
  • 產品註冊和臨床試驗申請
  • 監理文件的編寫和發布
  • 其他
  • 全球醫藥外包市場(依適應症、績效及預測),2019-2024 年、2024-2029 年、2034 年
  • 神經病學
  • 腫瘤學
  • 免疫學
  • 心臟病學
  • 其他
  • 全球醫藥事務外包市場:依類別、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 生技藥品
  • 藥物
  • 醫療設備
  • 其他
  • 全球醫藥事務外包市場:依公司規模、績效與預測,2019-2024 年、2024-2029 年、2034 年
  • 小的
  • 中等的
  • 大的
  • 全球醫藥外包市場(按最終用戶、業績和預測),2019-2024 年、2024-2029 年、2034 年
  • 醫療設備公司
  • 生技公司
  • 製藥公司
  • 全球製藥外包市場:法律代表細分、按類型、實際結果和預測,2019-2024 年、2024-2029 年、2034 年
  • 合規支持
  • 訴訟支持
  • 智慧財產權服務
  • 全球監管事務外包市場:監管諮詢細分、按類型、實際結果和預測,2019-2024 年、2024-2029 年、2034 年
  • 策略發展
  • 風險評估
  • 監管資訊
  • 全球醫藥外包市場:產品註冊和臨床測試細分,按類型、實際和預測,2019-2024 年、2024-2029 年、2034 年
  • 文件準備
  • 提交申請
  • 與監管機構的合作
  • 全球監管外包市場:監管文件編制和發布細分、按類型、實際和預測,2019-2024 年、2024-2029 年、2034 年
  • 臨床試驗報告
  • 監理備案
  • 科學出版品
  • 全球醫藥事務外包市場:其他細分市場、按類型、實際結果和預測,2019-2024 年、2024-2029 年、2034 年
  • 培訓與發展
  • 藥品安全監測
  • 品質保證和審核

第7章 區域和國家分析

  • 全球醫藥事務外包市場:依地區、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 全球醫藥事務外包市場:依國家、績效及預測,2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章:澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章:德國市場

第18章:法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章:競爭格局與公司概況

  • 監理事務外包市場:競爭格局
  • 監理事務外包市場:公司簡介
    • Thermo Fisher Scientific Inc.(PPD)
    • IQVIA
    • ICON plc
    • WuXi App Tec
    • Syneos Health

第31章:其他領先和創新企業

  • Catalent Pharma Solutions
  • Charles River Laboratories International. Inc.
  • Parexel International Corporation
  • Medpace
  • Curia
  • Certara LP
  • Amicus GMP
  • Pace Life Sciences
  • CTI Clinical Trial & Consulting
  • Accell Clinical Research LLC
  • Promedica International
  • Clinilabs Inc.
  • CliniExperts Pvt Ltd.
  • Global Regulatory Services(GRS)
  • Pharma Design Limited

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章:市場潛力大的國家與策略

  • 2029 年監理外包市場:提供新機會的國家
  • 2029 年監理外包市場:細分領域帶來新機會
  • 2029年監理事務外包市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r26949u

Regulatory affairs outsourcing involves external services utilized by pharmaceutical, biotech, and medical device manufacturing companies to expedite regulatory approvals from various organizations. These services encompass adherence to pharmaceutical regulations, quality standards, safety measures, efficacy criteria, and compliance with the attitudes and requirements of health authorities.

Regulatory affairs outsourcing services cover legal representation, regulatory consulting, product registration & clinical trial application, regulatory writing & publication, and others. Legal representation involves advocates handling legal work on behalf of pharmaceutical and medical device companies for regulatory approvals, covering medical devices, biologics, and drugs for various medical indications such as neurology, oncology, immunology, and cardiology. These outsourcing services are commonly adopted by companies in the medical device, biotechnology, and pharmaceutical sectors.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a notable impact on the services sector, particularly in business services, IT, and professional consulting. The increased costs of imported technology, office equipment, and critical digital infrastructure are driving up operating expenses for service providers, compelling them to either pass these costs on to clients or absorb the financial strain themselves. Outsourcing firms and IT service providers are grappling with higher hardware costs and supply chain delays, which are disrupting project timelines and squeezing profitability. Furthermore, retaliatory tariffs have weakened demand for U.S.-based professional services in key global markets, slowing export-driven revenues. To navigate these challenges, the sector must focus on accelerating digital transformation, optimizing costs, and strengthening domestic client relationships to sustain growth and remain competitive in an increasingly uncertain trade environment.

The regulatory affairs outsourcing market research report is one of a series of new reports from The Business Research Company that provides regulatory affairs outsourcing market statistics, including regulatory affairs outsourcing industry global market size, regional shares, competitors with regulatory affairs outsourcing market share, detailed regulatory affairs outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the regulatory affairs outsourcing industry. This regulatory affair outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The regulatory affairs outsourcing market size has grown rapidly in recent years. It will grow from $8.44 billion in 2024 to $9.43 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to globalization of regulatory standards, evolving regulatory landscape, industry-specific regulations, cost containment strategies, focus on core competencies.

The regulatory affairs outsourcing market size is expected to see rapid growth in the next few years. It will grow to $15.97 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to increasing complexity of submissions, digital transformation in regulatory processes, emphasis on compliance and risk management, shift in product development trends, growing complexity in submissions. Major trends in the forecast period include expansion of life sciences industry, sustainability and environmental regulations, demand for strategic guidance, utilization of advanced analytics, enhanced risk management.

The forecast of 14.1% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The U.S. is expected to see increased compliance management costs as regulatory intelligence platforms, cross-border dossier preparation tools, and automated audit systems sourced from Switzerland and India become more expensive to contract for pharmaceutical and medical device firms. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth in research and development (R&D) activities focused on new vaccines, therapeutics, and medical devices is expected to be a significant driver for the regulatory affairs outsourcing market. Companies operating in the medical device, pharmaceutical, and biotechnological sectors are intensifying their investments in R&D to create innovative products and expand their global reach. Concurrently, these companies are increasingly opting to outsource regulatory affairs to optimize operational costs and expedite the regulatory process by leveraging the expertise of professionals in the field. For example, a March 2022 report from the National Health Expenditures (NHE), prepared by the Office of the Actuary at the Centers for Medicare & Medicaid Services (CMS), forecasts an annual growth rate in national health spending averaging 5.1% from 2021 to 2030, reaching nearly $6.8 trillion by 2030. Consequently, the surge in R&D activities for new vaccines, therapeutics, and medical devices is expected to be a driving force behind the growth of the regulatory affairs outsourcing market.

The increase in the number of clinical trials is anticipated to drive the growth of the regulatory affairs outsourcing market in the future. Clinical trials are research studies that involve human participants to assess the safety and efficacy of new medical treatments, interventions, or diagnostic procedures. These trials utilize regulatory affairs outsourcing as a strategic method to streamline and accelerate the complex regulatory processes associated with drug development. By leveraging external expertise, companies can navigate changing compliance requirements and ensure effective interactions with regulatory authorities, which in turn helps to speed up the overall trial timeline and enable timely market access for new pharmaceutical interventions. For example, in November 2023, the Association of the British Pharmaceutical Industry, a UK-based trade association, reported that the annual number of industry clinical trials launched in the UK rose by 4.3%, increasing from 394 trials in 2021 to 411 in 2022. Therefore, the rising number of clinical trials is propelling the growth of the regulatory affairs outsourcing market.

The emergence of effective software for recording regulatory affairs is a significant trend gaining traction in the regulatory affairs outsourcing market. Leading companies in this sector are prioritizing the development of software that efficiently manages regulatory records. For instance, in May 2024, Rimsys, a US-based software firm, introduced the beta version of Rimsys Intel, a community-driven regulatory intelligence hub. This platform is free and specifically designed for the medical technology (medtech) sector, aimed at improving access to crucial information for the medtech community.

In January 2022, RQM+ Corp., a US-based MedTech service provider specializing in RA/QA consulting, acquired AcKnowledge Regulatory Strategies for an undisclosed sum. The acquisition is intended to bolster RQM+'s regulatory and quality consulting capabilities for medical devices and in-vitro diagnostics, providing comprehensive regulatory solutions to clients throughout the product lifecycle. AcKnowledge Regulatory Strategies is a US-based firm offering regulatory affairs consulting services.

In December 2023, SGS, a Switzerland-based multinational corporation, formed a partnership with Agilex Biolabs. This collaboration aims to strengthen SGS's footprint in the Asia-Pacific region, leveraging its extensive network of bioanalytical laboratories, including a newly established facility in Shanghai. The partnership is designed to facilitate seamless operational integration, ensuring efficient transfer and validation of methods across different locations. Agilex Biolabs is an Australia-based regulated bioanalytical laboratory that provides substantial support for drug development programs across various sectors, including small molecules and biologics.

Major companies operating in the regulatory affairs outsourcing market include Thermo Fisher Scientific Inc. (PPD), IQVIA, ICON plc, WuXi App Tec, Syneos Health, Catalent Pharma Solutions, Charles River Laboratories International. Inc., Parexel International Corporation, Medpace, Curia, Certara L.P., Amicus GMP, Pace Life Sciences, CTI Clinical Trial & Consulting, Accell Clinical Research LLC, Promedica International, Clinilabs Inc., CliniExperts Pvt Ltd., Global Regulatory Services (GRS), Pharma Design Limited, PharmaLex, Hiray Pharma Solutions, LGM Pharma, BlueReg Group

North America was the largest region in the regulatory affairs outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the regulatory affairs outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the regulatory affairs outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The regulatory affairs outsourcing market includes revenues earned by entities by providing services such as scope representation, full-service representation, ghostwriting representation, and fixed-rate representation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Regulatory Affairs Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on regulatory affairs outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for regulatory affairs outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The regulatory affairs outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Service: Legal Representation; Regulatory Consulting; Product Registration & Clinical Trial Application; Regulatory Writing & Publication; Other Services
  • 2) By Indication: Neurology; Oncology; Immunology; Cardiology; Other Indications
  • 3) By Category: Biologics; Drugs; Medical Devices; By Company Size: Small; Medium; Large
  • 4) By End User: Medical Device Company; Biotechnology Company; Pharmaceutical Company
  • Subsegments:
  • 1) By Legal Representation: Compliance Support; Litigation Support; Intellectual Property Services
  • 2) By Regulatory Consulting: Strategy Development; Risk Assessment; Regulatory Intelligence
  • 3) By Product Registration And Clinical Trial Application: Dossier Preparation; Application Submission; Liaison With Regulatory Authorities
  • 4) By Regulatory Writing And Publication: Clinical Study Reports; Regulatory Submission Documents; Scientific Publications
  • 5) By Other Services: Training And Development; Pharmacovigilance; Quality Assurance And Auditing
  • Companies Mentioned:Thermo Fisher Scientific Inc. (PPD); IQVIA; ICON plc; WuXi App Tec; Syneos Health; Catalent Pharma Solutions; Charles River Laboratories International. Inc.; Parexel International Corporation; Medpace; Curia; Certara L.P.; Amicus GMP; Pace Life Sciences; CTI Clinical Trial & Consulting; Accell Clinical Research LLC; Promedica International; Clinilabs Inc.; CliniExperts Pvt Ltd.; Global Regulatory Services (GRS); Pharma Design Limited; PharmaLex; Hiray Pharma Solutions; LGM Pharma; BlueReg Group
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Regulatory Affairs Outsourcing Market Characteristics

3. Regulatory Affairs Outsourcing Market Trends And Strategies

4. Regulatory Affairs Outsourcing Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Regulatory Affairs Outsourcing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Regulatory Affairs Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Regulatory Affairs Outsourcing Market Growth Rate Analysis
  • 5.4. Global Regulatory Affairs Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Regulatory Affairs Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Regulatory Affairs Outsourcing Total Addressable Market (TAM)

6. Regulatory Affairs Outsourcing Market Segmentation

  • 6.1. Global Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Legal Representation
  • Regulatory Consulting
  • Product Registration & Clinical Trial Application
  • Regulatory Writing & Publication
  • Other Services
  • 6.2. Global Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Neurology
  • Oncology
  • Immunology
  • Cardiology
  • Other Indications
  • 6.3. Global Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biologics
  • Drugs
  • Medical Devices
  • Other Categories
  • 6.4. Global Regulatory Affairs Outsourcing Market, Segmentation By Company Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Small
  • Medium
  • Large
  • 6.5. Global Regulatory Affairs Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medical Device Company
  • Biotechnology Company
  • Pharmaceutical Company
  • 6.6. Global Regulatory Affairs Outsourcing Market, Sub-Segmentation Of Legal Representation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Compliance Support
  • Litigation Support
  • Intellectual Property Services
  • 6.7. Global Regulatory Affairs Outsourcing Market, Sub-Segmentation Of Regulatory Consulting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Strategy Development
  • Risk Assessment
  • Regulatory Intelligence
  • 6.8. Global Regulatory Affairs Outsourcing Market, Sub-Segmentation Of Product Registration And Clinical Trial Application, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dossier Preparation
  • Application Submission
  • Liaison With Regulatory Authorities
  • 6.9. Global Regulatory Affairs Outsourcing Market, Sub-Segmentation Of Regulatory Writing And Publication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Study Reports
  • Regulatory Submission Documents
  • Scientific Publications
  • 6.10. Global Regulatory Affairs Outsourcing Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Training And Development
  • Pharmacovigilance
  • Quality Assurance And Auditing

7. Regulatory Affairs Outsourcing Market Regional And Country Analysis

  • 7.1. Global Regulatory Affairs Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Regulatory Affairs Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Regulatory Affairs Outsourcing Market

  • 8.1. Asia-Pacific Regulatory Affairs Outsourcing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Regulatory Affairs Outsourcing Market

  • 9.1. China Regulatory Affairs Outsourcing Market Overview
  • 9.2. China Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Regulatory Affairs Outsourcing Market

  • 10.1. India Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Regulatory Affairs Outsourcing Market

  • 11.1. Japan Regulatory Affairs Outsourcing Market Overview
  • 11.2. Japan Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Regulatory Affairs Outsourcing Market

  • 12.1. Australia Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Regulatory Affairs Outsourcing Market

  • 13.1. Indonesia Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Regulatory Affairs Outsourcing Market

  • 14.1. South Korea Regulatory Affairs Outsourcing Market Overview
  • 14.2. South Korea Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Regulatory Affairs Outsourcing Market

  • 15.1. Western Europe Regulatory Affairs Outsourcing Market Overview
  • 15.2. Western Europe Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Regulatory Affairs Outsourcing Market

  • 16.1. UK Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Regulatory Affairs Outsourcing Market

  • 17.1. Germany Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Regulatory Affairs Outsourcing Market

  • 18.1. France Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Regulatory Affairs Outsourcing Market

  • 19.1. Italy Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Regulatory Affairs Outsourcing Market

  • 20.1. Spain Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Regulatory Affairs Outsourcing Market

  • 21.1. Eastern Europe Regulatory Affairs Outsourcing Market Overview
  • 21.2. Eastern Europe Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Regulatory Affairs Outsourcing Market

  • 22.1. Russia Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Regulatory Affairs Outsourcing Market

  • 23.1. North America Regulatory Affairs Outsourcing Market Overview
  • 23.2. North America Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Regulatory Affairs Outsourcing Market

  • 24.1. USA Regulatory Affairs Outsourcing Market Overview
  • 24.2. USA Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Regulatory Affairs Outsourcing Market

  • 25.1. Canada Regulatory Affairs Outsourcing Market Overview
  • 25.2. Canada Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Regulatory Affairs Outsourcing Market

  • 26.1. South America Regulatory Affairs Outsourcing Market Overview
  • 26.2. South America Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Regulatory Affairs Outsourcing Market

  • 27.1. Brazil Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Regulatory Affairs Outsourcing Market

  • 28.1. Middle East Regulatory Affairs Outsourcing Market Overview
  • 28.2. Middle East Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Regulatory Affairs Outsourcing Market

  • 29.1. Africa Regulatory Affairs Outsourcing Market Overview
  • 29.2. Africa Regulatory Affairs Outsourcing Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Regulatory Affairs Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Regulatory Affairs Outsourcing Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Regulatory Affairs Outsourcing Market Competitive Landscape And Company Profiles

  • 30.1. Regulatory Affairs Outsourcing Market Competitive Landscape
  • 30.2. Regulatory Affairs Outsourcing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. (PPD) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. IQVIA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. ICON plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. WuXi App Tec Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Syneos Health Overview, Products and Services, Strategy and Financial Analysis

31. Regulatory Affairs Outsourcing Market Other Major And Innovative Companies

  • 31.1. Catalent Pharma Solutions
  • 31.2. Charles River Laboratories International. Inc.
  • 31.3. Parexel International Corporation
  • 31.4. Medpace
  • 31.5. Curia
  • 31.6. Certara L.P.
  • 31.7. Amicus GMP
  • 31.8. Pace Life Sciences
  • 31.9. CTI Clinical Trial & Consulting
  • 31.10. Accell Clinical Research LLC
  • 31.11. Promedica International
  • 31.12. Clinilabs Inc.
  • 31.13. CliniExperts Pvt Ltd.
  • 31.14. Global Regulatory Services (GRS)
  • 31.15. Pharma Design Limited

32. Global Regulatory Affairs Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Regulatory Affairs Outsourcing Market

34. Recent Developments In The Regulatory Affairs Outsourcing Market

35. Regulatory Affairs Outsourcing Market High Potential Countries, Segments and Strategies

  • 35.1 Regulatory Affairs Outsourcing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Regulatory Affairs Outsourcing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Regulatory Affairs Outsourcing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer